Current API product portfolio
| Products | EuDMF | USDMF | CEP | Other documentation |
| Acetazolamide |  |
|
filed | |
| Acetylsalicylic acid | |
|
||
| Aciclovir | |
|||
| Alendronate sodium | |
|
|
Japanese DMF |
| Aripiprazole | |
|
||
| Baclofen | |
|
|
Japanese DMF |
| Bosentan | |
|||
| Carbamazepine | |
in preparation | |
|
| Carvedilol | |
|
|
|
| Carvedilol phosphate hemihydrate | |
|||
| Chlorpropamide | |
|
||
| Cholecalciferol | |
|
||
| Clopidogrel bisulphate | |
|||
| Cyclobenzaprine hydrochloride | |
|
||
| Darifenacin hydrobromide | |
|
||
| Diclofenac sodium | |
|||
| Dohyfral D3 2000 AG | |
|
||
| Enalapril maleate | |
|
||
| Entacapone | Applicant's Part | |||
| Ethenzamide | Applicant's Part | |||
| Etodolac | ||||
| Hydrochlorothiazide | |
|
|
Japanese DMF |
| Ibandronate sodium | |
|
||
| Lamotrigine | |
|
|
|
| Magnesium aspartate | |
|||
| Metoclopramide hydrochloride | |
|||
| Metoprolol succinate | |
|
filed | |
| Metoprolol tartrate | |
filed | ||
| Metronidazole | |
|||
| Montelukast sodium | |
|
||
| Opipramol dihydrochloride | |
|||
| Paricalcitol | |
|
||
| Pentoxifylline | |
|
|
|
| Phenyl salicylate | Applicant's Part | |||
| Piracetam | |
|
||
| Repaglinide | |
|
filed | |
| Risedronate sodium | |
|
Japanese DMF | |
| Rosuvastatin calcium | |
|
||
| Salicylamide | |
|||
|
Sildenafil ba |
|
|||
| Sildenafil citrate | |
|
||
| Sodium salicylate | |
|||
| Sulfadimethoxine | Applicant's Part | |
||
| Sulfadimethoxine sodium | |
|||
| Tadalafil | |
|
||
| Tinidazole | |
|
||
| Tolbutamide | |
|
||
| Tolterodine | |
|
||
| Topiramate | |
|
||
| Vardenafil hydrochloride | |
|
||
| Zoledronic acid | |
|
Latest news
CEP for Baclofen available
Monday, 02-01-2012
Polpharma has been granted Certificate of Suitability (CEP) by the European Directorate for the Quality of...
Polpharma – the most innovative company in Poland
Friday, 20-05-2011
Polpharma ranked first as the most innovative company in Poland, in a research study run by the Institute...
Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex
Friday, 08-10-2010
Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex for the...
Co-operation between Polpharma and RPG Life Sciences
Tuesday, 05-10-2010
RPGLS and Polpharma announced their co-operation in the development and manufacture of Active...